| Filed On | Filing |
|---|---|
| 22 Oct 2026 | EFFECT |
| 22 Oct 2026 | 424B3 |
| 13 Oct 2026 | S-1 |
| 21 Sep 2026 | SCHEDULE 13G |
| 21 Aug 2026 |
Form 4: Roth Jason Aaron, See Remarks
Received 34,098 shares as a grant or award |
| 18 Aug 2026 | 8-K: Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities |
| 14 Aug 2026 | SCHEDULE 13G |
| 12 Aug 2026 | SCHEDULE 13G |
| 12 Aug 2026 | SCHEDULE 13G |
| 30 Jul 2026 | 10-Q |
| 29 Jul 2026 | 8-K: Results of Operations and Financial Condition |
| 01 Jul 2026 |
Form 4: Jankowski Ryan Anthony, Chief Accounting Officer
Received 8,517 shares as a grant or award |
| 02 Jun 2026 | 8-K: Entry into a Material Definitive Agreement; Other Events |
| 28 May 2026 | 8-K: Results of Operations and Financial Condition |
| 28 May 2026 | 10-Q |
| 20 Apr 2026 |
Form 4: Jankowski Ryan Anthony, Chief Accounting Officer
Received 46,867 shares as a grant or award · Bought 4,464 shares ($125K) |
| 20 Apr 2026 |
Form 4: Allen Jennifer H., See Remarks
Received 53,695 shares as a grant or award |
| 20 Apr 2026 |
Form 4: Badakhsh Azad Sid, See Remarks
Received 367,864 shares as a grant or award · Bought 36,000 shares ($1.01M) |
| 20 Apr 2026 |
Form 4: Sealfon Ross Bradley, See Remarks
Received 1,090,307 shares as a grant or award · Bought 12,500 shares ($350K) |
| 20 Apr 2026 |
Form 4: Oetgen Stephen Duane, Director
Received 5,357 shares as a grant or award · Bought 25,000 shares ($700K) |
Loading...